Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 8 711-717, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy

M Sawada, M Kubota, YW Lin, K Watanabe, S Koishi, I Usami, Y Akiyama, T Matsumura and K Furusho
Department of Pediatrics, Kyoto University, Japan.

Mutant frequencies (MFs) at the hypoxanthine phosphoribosyl transferase gene and the T-cell receptor (TCR) gene loci were evaluated in nine pediatric cancer patients before and during anticancer chemotherapy. The study population consisted of three patients with Hodgkin's disease, four patients with neuroblastoma, and two patients with Wilms' tumor. Except for one patient with neuroblastoma and one patient with Wilms' tumor, MFs at the hypoxanthine phosphoribosyl transferase locus tended to increase during the early cycles of treatment. The elevation was most striking and persistent in patients with Hodgkin's disease. The clonal relationship was determined in mutant cells derived from Hodgkin's disease patients by TCR-gamma gene rearrangement pattern and showed that the elevation of MFs resulted from increased mutational events rather than from clonal expansion of mutants. An increase in TCR MF was also found during chemotherapy in most patients, but the time of TCR MF elevation was variable among patients. Among the chemotherapeutic agents used in this study, cyclophosphamide was considered to be the most mutagenic. Our present study clearly demonstrates that anticancer chemotherapy can induce mutagenesis in vivo in various pediatric cancer patients.

This article has been cited by other articles:

				S. C. Rice, P. Vacek, A. H. Homans, T. Messier, J. Rivers, H. Kendall, and B. A. Finette Genotoxicity of Therapeutic Intervention in Children with Acute Lymphocytic Leukemia Cancer Res., July 1, 2004; 64(13): 4464 - 4471. [Abstract] [Full Text] [PDF]

				B. J.S. Sanderson, K. J. Johnson, and W.D. Henner Induction of mutant lymphocytes in cyclophosphamide- and chlorambucil-treated patients Mutagenesis, May 1, 2001; 16(3): 197 - 202. [Abstract] [Full Text] [PDF]